1. South Korea Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Value Added Technology Co., Ltd.

Value Added Technology Co., Ltd.

KKRX:043150
16,610.00
KRW
-90.00
(-0.54%)
2,803.39EPS
7.61P/E
321.59BMarket Cap
Nov 11Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
11,714.19
13,228.79
14,629.62
12,018.86
14,732.36
15,778.86
18,291.71
16,442.56
22,819.07
26,593.82
25,916.31
25,934.29
28,702.41
28,968.02
Basic EPS, GAAP
388
659
1,433
1,667
5,325
1,835
2,281
-1,630
3,449
5,176
3,483
3,712
2,701
2,845.75
Free Cash Flow per Basic Share
-881.37
-257.35
-381.6
-79.71
2,152.24
1,589.96
2,192.95
2,926.54
2,152.28
1,277.35
259.81
1,003.08
3,299.89
2,782.77
Dividend per Share
99.69
99.52
99.98
99.98
100.01
100
183.07
193.77
99.99
99.99
100.01
143.66
99.99
- -
Book Value per Share
5,658.08
5,894.65
6,830.62
9,884.18
13,196.39
14,751.62
16,729.83
14,979.37
18,393.6
23,514.22
26,837.38
30,524.31
33,371.05
34,367.37
Tangible Book Value per Share
4,640.63
5,106.08
5,537.4
7,839.86
12,414.12
13,991.7
15,915
14,538.88
18,214.21
22,911.4
26,720.6
30,443.82
33,153.28
34,153.18
Basic Weighted Avg Shares
15
15
15
15
15
15
15
15
15
15
15
15
15
15
Sales/Revenue/Turnover
171,517
194,791
217,359
178,561
218,809
234,393
271,703
244,312
338,980
395,056
384,945
385,195
426,416
430,298
Operating Margin (%)
8.93
16.25
18.86
16.72
17.86
16.79
15.78
12.93
19.33
20.16
16.64
14.01
12.85
12.22
Depreciation Expense
7,131
7,792
8,203
11,189
7,317
7,576
10,144
10,839
9,861
11,578
14,615
15,086
16,866
16,946
Net Income, GAAP
5,681
9,704
21,291
24,766
79,088
27,259
33,882
-24,219
51,235
76,890
51,734
55,133
40,127
42,272
Effective Tax Rate (%)
25.83
3.67
19.16
24.37
26.18
28.13
26.12
- -
25.39
19.42
20.63
23.57
29.16
29.21
Profit Margin (%)
3.31
4.98
9.8
13.87
36.14
11.63
12.47
-9.91
15.11
19.46
13.44
14.31
9.41
9.82
Working Capital
48,740
52,335
60,062
152,419
59,884
84,095
101,330
113,803
149,053
169,489
204,992
229,802
265,829
283,578
LT Debt
15,048
12,660
23,915
25,696
28,895
27,134
29,207
24,398
16,082
19,016
25,143
16,297
17,697
16,680
Total Equity
104,721
113,025
134,002
257,043
198,611
223,694
253,761
228,868
284,556
363,433
414,192
470,489
497,521
512,205
Return on Invested Capital (%)
7.08
17.18
16.28
8.07
9.76
10.62
11.14
- -
16.6
17.69
11.78
8.45
7.31
6.81
Return on Capital (%)
-0.26
5.91
7.7
6.55
26.07
10.14
11.93
- -
16.84
21.96
12.49
11.76
8.15
8.22
Return on Common Equity (%)
7.16
11.38
22.53
19.95
46.14
13.13
14.49
-10.28
20.67
24.7
13.83
12.94
8.46
8.63

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
25,081
26,568
27,117
LT Borrowings
127
99
68
LT Finance Leases
16,771
17,598
16,612
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
15
15
15
Market Capitalization
329,022
290,401
321,595

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
364,627
392,702
420,522
Cash, Cash Equivalents & STI
116,204
138,745
143,401
Accounts Receivable, Net
111,313
120,941
129,050
Inventories
119,956
116,649
129,164
Total Current Liabilities
108,493
126,873
136,944
Payables & Accruals
- -
- -
- -
ST Debt
25,081
26,568
27,117
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
17.07%
17.07%
5.75%
Free Cash Flow
-246.48%
73.67%
229.06%
Net Income, GAAP
-29.19%
-62.97%
-27.22%
Sales/Revenue/Turnover
8.11%
12.7%
10.7%
Total Cash Common Dividend
- -
- -
-30.38%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
94,227
101,980
87,279
101,707
385,195
2025
101,316
110,618
100,113
114,368
426,416
2026
105,198
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,122
1,040
479
1,070.24
3,712
2025
829
491.27
934.83
446.73
2,701
2026
972.93
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
143.66
2025
- -
- -
- -
- -
99.99
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Gyu-Ho Hwang
Full Time Employees
313
Sector
Health technology
Industry
Medical specialties
Address
37, Gwahaksaneop 2-ro 20beon-gil, Jillye-myeon Hwaseong-si GY South Korea 50877
IPO Date
Sep 29, 2006
Website
vatech.co.kr
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Value Added Technology Co., Ltd. (Vatech) manufactures and sells dental medical X-ray devices and related imaging solutions. The company offers 3D and 2D imaging systems, IOS/IOX intraoral dental imaging systems, CT and panoramic X-ray medical imaging devices, and 2D/3D dental software products under the Davis brand; it provides advanced diagnostic tools including cone-beam computed tomography (CBCT), intraoral scanners, intraoral sensors, and facial scanners. Vatech operates in the healthcare equipment and supplies sector, targeting dental professionals and clinics with low-dose digital X-ray technologies. Founded in 1992 and headquartered in Hwaseong-si, South Korea, the company conducts business in Korea, Asia, Australia, Europe, North and South America, and the Middle East. Recent developments include the August 2025 U.S. launch of Clever One, an FDA-cleared AI-powered all-in-one dental viewer platform integrating panoramic, CBCT, intraoral, facial, and STL scan data with features such as AI lesion detection, 3D segmentation, root canal analysis, implant simulations, and cloud integration developed through partnerships with AI firms like Pearl; the October 2025 initiation of the Boundless Campaign featuring software updates to Green X units reducing patient scan times for elderly comfort; and the introduction of the enhanced Smart Plus intraoral X-ray system with denoising imaging, extended FOV, and up to 10-year warranties.